UNSPSC 51314380: Pseudoephedrine/terfenadine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE501. This VA Drug Class (RE501) classifies this compound as belonging to the group ANTIHISTAMINE/DECONGESTANT.

UNSPSC 51314380 Pseudoephedrine/terfenadine is a Commodity code that does not align with the recent state and local opportunities tagged to it. The three most recent opportunities solicited under this code involve naloxone and drug deactivation systems, therapeutic pharmacy initiative direct-to-manufacturer prescriptions, and generic multi-source pharmaceuticals and OTC products — none of which are pseudoephedrine or terfenadine formulations. The code shows little relevant recent activity in the state and local market.

The mismatch between the code's nominal scope and actual procurement activity suggests that the tagging reflects a data classification error rather than genuine demand for pseudoephedrine or terfenadine-specific procurement at state and local levels. The three opportunities span different issuing bodies and geographies — Seminole County, Florida (naloxone and drug deactivation systems through IFB); Texas Health and Human Services Commission (RFI on direct-to-manufacturer pharmacy initiatives); and Minnesota Multistate Cooperative Purchasing Alliance serving multiple state and local jurisdictions (generic pharmaceuticals and OTC products RFP) — but none target the products named in the code. Business development professionals evaluating this code should verify current procurement intent through direct engagement with state pharmacy purchasing offices and health authorities, as the available opportunity records do not provide reliable signal for this specific commodity.